Filing Details
- Accession Number:
- 0001104659-24-125969
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-05 18:14:34
- Reporting Period:
- 2024-12-03
- Accepted Time:
- 2024-12-05 18:14:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786966 | Badreddin Edris | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-12-03 | 11,966 | $41.78 | 217,634 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-12-03 | 8,034 | $42.24 | 209,600 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.09 to $42.085. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.555. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.